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summary
Introduction. the ha and na proteins are in the lipid envelope of virions. the ha and na are an integral membrane proteins 
and its neuraminidase activity is required for efficient release of viral particles from the infected cell. neuraminidase activity 
might be measured by neuraminidase inhibition assay. 
Aim. the present study is aimed at testing the usability of a new method which allow for the detection and quantification of 
neuraminidase inhibiting antibodies. 
Material and methods. the results of the four methodologies were compared with each other: takátsy-assay, elisa-micro-
neutralization assay, cPe-microneutralization assay and new neuraminidase inhibition (ni) assay lectin peanut agglutinin 
conjugated peroxidase (Pna) technique. haemagglutinin inhibition is a traditional method was used as the “gold standard” in 
our investigations.
human sera have been used in our studies which obtained from vaccinated people. inactivated seasonal influenza vaccines have 
been in development for over 50 years in hungary. inactivated vaccines contain a trivalent mixture of inactivated strains of the 
influenza viruses likely to circulate during the next influenza season. inactivated whole-virus influenza vaccine is administered 
intramuscularly. after vaccination the humoral antibody levels are detected against to influenza virus surface antigens: haemag-
glutinin (ha), neuraminidase (na) virus-specific neutralizing antibodies to influenza viruses.
Results. after seasonal vaccination induced neuraminidase inhibiting (ni) serum antibody titers detected by Pna and the 
takátsy-assay are correlated. Pna assay is a very sensitive assay, resulting in significantly higher ni titers as compared to the 
takátsy-assay. ni serum titers detected by Pna and haemagglutinin inhibiting titers are highly correlated.
Conclusions. this new ni method is useful to better standardize influenza vaccines’ immunological requirements prior to their 
commercialisation and it can be usefully assay in microbiological labs, as it is very easy to standardize.
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INtroDUCtIoN 
there are two external glycoprotein components 
coded by virus genome on the surface of influenza vi-
rus particles. the HA protein is responsible for attach-
ment and infection of the host cell and is the most im-
munogenic protein of the virus (1). the present study 
is aimed at testing the usability of a new method which 
allow for the detection and quantification of NA antibod-
ies. Neuraminidase is an enzyme on the surface of influ-
enza viruses that cleaves terminal sialic acid from sugar 
residues and from glycoproteins and so releases virus 
from the infected cells. Neuraminidase activity might be 
mesured by NI assay. this assay is based upon enzy-
matic removal by NA of the sialic acid residual of the fe-
tuin. When a neuramindase substrate is coated on to the 
wells of a microplate and peroxidase conjugated peanut 
agglutinin recognizes and binds the free galactose, it is 
possible to quantitate the binding of PNA. the amount 
of bound PNA correlated directly with te amount of sial-
ic acid removed from the substrate and therefore with 
the neuraminidase activity (2, 3). Neuraminidase inhibi-
tion (NI) test is used for the titration of antibodies against 
neuraminidase antigen in human sera. By reacting with 
specific epitopes that are located near to the enzyme 
active site, anti-neuraminidase antibodies are capable 
of inhibiting the virus induced desialylation of the sub-
strate. Such antibodies therefore reduce the binding of 
peroxidase conjugated peanut agglutinin.
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be observed. In 1995, a private Hungarian company, 
omninvest Ltd. received a national marketing authori-
zation for flu vaccine produced by the use of the same 
method, containing inactivated whole virus and AlPo4 
as an adjuvant.
In this report, we used following procedure. the 96-
-weel microplates coated with fetuin (50 µg/ml in 0.1 M 
Carbonate-Bicarbonate Buffered Solution), 150 µl/well 
overnight at +4°C or 1 hour + 37°C. Wash with 350 µl/well 
PBS Buffer containing 0.5% tWEEN 20. the viruses 
must be standardized to have a 4 x oD value of the 
blank. Dilute viruses’ 2-scale and add 100 µl to each 
well overnight at +37°C and wash. Add 100 µl PNA 
(2 µg/ml in PBS) to each well and incubate 1 hour in 
room temperature. After washing add 100 µl oPD + 
UrEA (substrate) to each well and the reaction then 
stopped by adding 100 µl/well 1N H2So4. read results 
on 492-620 nm by ELISA-reader. Neuraminidase inhi-
bition test: the sera ere diluted a 2-scale in PBS. A mix-
ture of 50 µl of standardized viral suspension and 50 µl 
of diluted serum, overnight at +37°C and wash. result 
of the PNA and oPD + UrEA reaction measured were 
made ELISA reader as well as the virus standardization 
assay. 
rESULtS
the results of the four methodologies were compared 
with each other and with the HAI assay. HAI assay was 
used as the “gold standard” in our investigations. ELISA 
virus neutralization test and PNA NI test was the most 
sensitive methods and these tests are more objective re-
sults. there is a comparative study between NI takátsy 
spectrophotometric methodology and the PNA system.
the test results correlate with each other (tab. 1). 
thus 8 sera-pairs were role of PNA method in the N1 
specific test. 7 sera pairs showed seroconversion. top 
of results proved in No. 2, 4, 6, 7 and 8. the No. 9 sera-
pair was not shown titer increase.
6 sera pairs showed seroconversion in the N2 spe-
cific test. top of results proved in No. 3, 4, 5, 6, 8. No. 9 
sera-pair was not shown titer increase.
5 sera pairs showed seroconversion in the B specific 
test. top of results proved in No. 6, 7, and 8. No. 9 sera-
pair was not shown 4-times titer increase as it is N1, N2 
specific NI test. 
No. 4, 6, 7 and No. 8 sample pairs had NI respons-
es induced after seasonal influenza vaccination for all 
three (N1, N2, B) against influenza subtypes.
In the N1, N2 and B specific tests of PNA-PoD (ELI-
SA) there were 9 sera-pairs. 
In the N1 specific test there was a few of sera in No. 1 
sera-pair for assay. thus 8 sera-pairs were role of this 
method. 7 sera pairs showed seroconversion. In the re-
sults of pre-vaccination sera (No. 2-No. 9) were observed 
about 40 dilution values. In contrast the results of post-
vaccination sera were observed between 40-1280 dilu-
AIM
the present study is aimed at testing the usability of 
a new method which allow for the detection and quanti-
fication of NA antibod ies. 
MAtErIAL AND MEtHoDS 
Virus preparations (4): the following virus strain were 
grown in 10 day-old embrionated chicken eggs:
 – A/New Caledonia/20/99 (H1N1)-like strain (A/New Ca- 
ledonia/20/99 [IVr-116]), 
 – A/Wisconsin/67/2005 (H3N2)-like strain (A/Wisconsin 
/67/2005 [NYMC X-161]),
 – B/Malaysia/2506/2004-like strain (B/Malaysia/2506 
/2004).
Preparation of hyper immune sera: Chickens were 
immunized intravenously and boosted 3 weeks later. 
Whole blood was obtained by cardiac puncture ap-
proximately 4 weeks after the boost and sera stored at 
-20°C. the chicken antisera were specific for the inocu-
lating strain as demonstrated by HA and NA inhibition 
assay.
Haemagglutination inhibition test (HI) (5): HA 
was quantified based on a method described by 
Hirst (1942) (6) and then later modified by Salk (1944) (7). 
this traditional method for identifying subtype of influ-
enza isolates, and is usually more rapid than serological 
diagnosis.
the microneutralization assay (VN) (5): this test is 
a highly sensitive and specific assay for detecting virus-
specific neutralizing antibodies to influenza viruses. the 
VN test was evaluated by ELISA or CPE (Cytopathogen-
ic Effect) assay.
Neuraminidase inhibition assays (NI): NI test is used 
for the titration of antibodies against neuraminidase anti-
gen in human sera. Neuraminidase is an enzyme on the 
surface of influenza viruses that cleaves terminal sialic 
acid from sugar residues and from glycoproteins and so 
releases virus from the infected cells.
takátsy-assay (8): the NA activity and NI (9) micro-
method assay based on Warren’s colour reaction (9) 
that modified later by takátsy and Barb (1978). Stan-
dard tBA Assay: Neuraminidase-inhibition by antibody 
is measured according to the thiobarbituric acid (tBA) 
assay for the free sialic acid released from fetuin in solu-
tion. A colour development is measured.
Peroxidase-conjugated Lectin Peanut Agglutinin 
assay (PNA): Using fetuin as a substrate neuramini-
dase activity can be mesured (10). After the coating of 
fetuin on 96-well plates sera and standardised amount 
of viruses are mixed and added to the wells. After in-
cubation and wash PNA is added, it binds to free ga-
lactose and is detected using an enzyme-linked im-
munosorbent assay. the amount of PNA that is bound 
is proportional to the amount of neuraminidase that 
is present. Changes in the NI titers of sera collected 
before and after vaccination with influenza virus can 
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table 1. Comparison NI titers of the sera pairs with PNA test and takátsy-NI methods.
Virus 
strain
NAI titers PNA-POD (ELISA)
1
1/2
2
1/2
3
1/2
4
1/2
5
1/2
6
1/2
7
1/2
8
1/2
9
1/2
N1 */1280 40/640 40/160 40/640 40/320 40/1280 40/640 80/1280 < 40/< 40
N2 < 40/80 1280/1280 160/640 < 40/160 160/640 640/2560 640/640 40/640 160/160
B 160/640 320/640 160/320 80/640 320/640 160/1280 40/1280 80/1280 80/160
Virus 
strain
NAI titers Spectrophotometric detection (Takátsy)
1
1/2
2
1/2
3
1/2
4
1/2
5
1/2
6
1/2
7
1/2
8
1/2
9
1/2
N1 */* 2/16 2/8 2/4 2/8 2/16 2/8 2/8 2/4
N2 1/1 8/16 8/8 1/1 1/8 4/16 4/8 1/8 4/4
B 0/0 8/64 16/32 4/32 16/32 16/128 1/128 8/64 8/16
N1 – A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 [IVr-116]); N2 – A/Wisconsin/67/2005 (H3N2)- 
-like strain (A/Wisconsin/67/2005 [NYMC X-161]); B – B/Malaysia/2506/2004-like strain (B/Malaysia/2506/2004); 1-9 
– number of samples; 1/2 – serum pairs (pre-vaccination serum/collected serum 2 weeks after vaccination); *few serum
Fig. 1. Comparison of the results of the four test methods showed seroconversion (four-time titer increase between first and second 
sera) observed in results of the No. 2 and No. 6 sample pairs in all laboratory assay. No. 9 sera-pair was not shown 4-times titer 
increase. the correlation coefficient value of  ~ 0.8 indicates that there is significant association between the HI and PNA method. 
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No. 9 sera-pair was not shown 4-times titer increase 
(80/160) as it is N1, N2 specific test. 
No. 4, No. 6, No. 7, and No. 8 sample pairs had NI 
responses induced after seasonal influenza vaccination 
for all three (N1, N2, B) against influenza subtypes.
In the N2 and B specific tests of takátsy-spectro-
photometric detection methodology there were 9 sera-
pairs. 
In the N1 specific test there was a few of sera in No. 1 
sera-pair for assay. thus 8 sera-pairs were role of this 
method. 6 sera pairs showed seroconversion (fig. 1). In 
the results of pre-vaccination sera (No. 2-No. 9) were 
observed 2 dilution values. In contrast the results of 
post-vaccination sera were observed between 4-16 di-
lution values. top of results proved in No. 2 (2/16) and 
No. 6 (2/16).
No. 4 and 9 sera-pairs were not shown 4-times titer 
increase (2/4) (fig. 2).
tion values. top of results proved in No. 2 (40/640), No. 
4 (40/640), No. 6 (40/1280), No. 7 (40/640), and No. 8 
(80/1280). No. 9 sera-pair was not shown titer increase.
In the N2 specific test were 6 sera pairs showed 
seroconversion. In the results of pre-vaccination 
sera (No. 1-No. 9) were observed between 80-1280 dilu-
tion values. In contrast the results of post-vaccination 
sera were observed between 80-2560 dilution values. 
top of results proved in No. 3 (160/640), No. 4 (< 40/160), 
No. 5 (160/640), No. 6 (640/2560), No. 8 (40/640). No. 9 
sera-pair was not shown titer increase.
In the B specific test were 5 sera pairs showed sero-
conversion. In the results of pre-vaccination sera (No.1-
No. 9) were observed 40-320 dilution values. In contrast 
the results of post-vaccination sera were observed be-
tween 160-1280 dilution values. top of results proved in 
No. 6 (160/1280), No. 7 (40/1280), and No. 8 (80/1280). 
results of spectrofotometric detection results of PNA (ELISA)
Comparison of seroconversion
Fig. 2. Comparison N1 specific NI titers of the sera pairs obtained with PNA test and takátsy-methods. there is a significant dif-
ference between the PNA and takátsy test. the NI titers are different significantly from pre-and post-vaccination sera. there are 
4-times or high than 4-times rate of increase in titers with the exception of No. 9 sample-pair. the correlation coefficient value of 
0.5 indicates which is a weak relationship between the two test results. Low correlation coefficient can be explained by the PNA- 
-PoD assay found a higher titer differences.
151New Medicine 
4/2015
Detection of neuraminidase-inhibiting antibodies for measurement of influenza vaccine immunogenicity
No. 7 (8/64). No. 2, 4 sera-pairs were not shown 4-times 
titer increase. 
No. 5, No. 6, No. 8 sample pairs had NI responses 
induced after seasonal influenza vaccination for all 
three (N1, N2, B) against subtypes.
N1 specific tests
Comparison N1 specific NI titers of the sera pairs ob-
tained with the different test methods. VN test and PNA- 
-PoD test can be read with ELISA reader which allows 
objectively assessment. the takátsy NI and CPE-VN 
test methods are highly subjective because these can-
not be read by ELISA reader. the correlation coefficient 
value of 0.774132 indicates that there is significant as-
sociation between the HAI (gold standard method) and 
PNA-PoD method (fig. 1, fig. 2). 
In the N2 specific test were 3 sera pairs showed 
seroconversion. In the results of pre-vaccination 
sera (No. 1-No. 9) were observed between 1-8 di-
lution values. In contrast the results of post-vacci-
nation sera were observed between 1-16 dilution 
values (fig. 3). top of results proved in No. 5 (1/8), 
No. 6 (4/16), No. 8 (1/8). No. 1, 2, 3, 4, 7 and 9 sera-
pairs were not shown titer increase (1/1, 8/16, 8/8, 
1/1, 4/8, 4/4).
In the B specific test there was a few of sera in No. 9 
sera-pair for assay. 5 sera pairs showed seroconver-
sion. In the results of pre-vaccination sera (No. 1-No. 8) 
were observed between 1-16 dilution values. In contrast 
the results of post-vaccination sera were observed be-
tween 16-128 dilution values. top of results proved in 
No. 1 (8/64), No. 3 (4/32), No. 5 (16/128), No. 6 (1/128), 
Fig. 3. Comparison N2 specific N2 titers of the sera pairs obtained with the different test methods. VN test and PNA-PoD test can 
be read with ELISA reader which allows objectively assessment. the takátsy N2 and CPE-VN test methods are highly subjective 
because these cannot be read by ELISA reader.
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N2 specific tests
Comparison of the results of the four test methods 
showed seroconversion (four-time titer increase be-
tween first and second sera) observed in results of the 
No. 5 sample pairs in all laboratory assay. No. 9 sera-
pair also was not shown 4-times titer increase such as 
the N1 specific NI assay. We found no high titer differ-
ences between the first and second sera in contrast 
N1-specific NI tests were shown extremely high titer 
differences. the correlation coefficient value of 0.7 in-
dicates that there is significant association between 
the HI (gold standard method) and PNA method. the 
correlation coefficient value was similar (0.8) in the N1-
specific NI assays. 
there is a significant difference between the PNA and 
takátsy test. the NI titers are different from pre- and post- 
-vaccination sera. there are 4-times or high than 
4-times rate of increase in titers of No. 5, 6, 8 sample-
pairs in both of test. there was no increase in titer for 
results of spectrofotometric detection results of PNA (ELISA)
Comparison of seroconversion
Fig. 4. Comparison N2-specific NI titers of the sera pairs obtained with PNA test and takátsy-NI methods.
No. 2, 7, 9 sample-pairs in none of test. the correlation 
coefficient approaches to 1: value of 0.96 indicates that 
there is a significant correlation between the two meth-
ods (fig. 4).
B specific test
Comparison of the results of the four test methods 
showed seroconversion (four-time titer increase be-
tween first and second sera) observed in results of the 
No. 4 and 8 sample pairs in all laboratory assay. No. 5 
and 9 sera-pairs was not shown 4-times titer increase. 
titer differences were not found in any tests, under 
investigation of the No. 9 sample pair. We found high 
titer differences between the first and second sera as 
well as N1-specific NI tests were also shown extreme-
ly high titer differences (fig. 5). the correlation coef-
ficient value of 0.67 indicates that there is significant 
association between the HI (gold standard method) 
and PNA method. the correlation coefficient values 
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observed against N2 influenza vaccine strains that is part 
of the seasonal trivalent influenza vaccine and 66% se-
roconversion by PNA assay, 33% by takátsy assay. the 
humoral immune response was around 89% against B 
influenza vaccine strain by HI assay and 56% seroconver-
sion by PNA assay, 56% by takátsy assay. 
the NI antibody responses are significantly induced 
after vaccination.
Highest prevalence rates of NI seroconversion are 
induced N1 specific NI responses and the lowest pro-
portion of of seroconversion are induced B specific NI 
responses. 
there is 4 x differences between the first and second 
serum titers for both of methodology. the PNA system 
is much more sensitive and there is an implementation 
method is simpler and cheaper. tenth part of sample 
volume is required for the PNA test compared to takátsy 
method. the standardization of viruses is enough amni-
were 0.8 in the N1-specific NI assay and 0.7 in the N2-
specific NI assay. 
there is a significant difference between the PNA and 
takátsy-NI test. the NI titers are different from pre-and 
post-vaccination sera. there are 4-times or high than 
4-times rate of increase in titers of No. 4, 6, 7, 8 sample-
pairs in both of test. there was no increase in NI titer for 
No. 3, 5, 9, sample-pairs in none of test. the correlation 
coefficient approaches to 1: value of 0.91 indicates that 
there is a significant correlation between the two meth-
ods (fig. 6).
DISCUSSIoN
HI antibody responses are significantly induced after 
vaccination (fig. 7). It was around 75% seroconversion by 
HI assay against strain N1 of the trivalent seasonal influ-
enza vaccine and 87.5% seroconversion by PNA assay, 
66% by takátsy assay. Around 45% seroconversion was 
Fig. 5. Comparison B specific NI titers of the sera pairs obtained with the different test methods. VN test and PNA test can be read 
with ELISA reader which allows objectively assessment. the takátsy NI and CPE-VN test methods are highly subjective because 
these cannot be read by ELISA reader.
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otic and allantoic fluid, unlike takátsy’s system in which 
is required for the concentrated virus strains and it is 
more expensive and time-consuming method.
CoNCLUSIoNS
After seasonal vaccination induced NI serum titers 
detected by PNA and the takátsy-assay are correlated. 
PNA assay is a very sensitive assay, resulting in signifi-
cantly higher NI titers as compared to the tBA assay. 
NI serum titers detected by PNA and HI titers are highly 
correlated. PNA technique can be useful assay in micro-
biological labs, as it is very easy to standardize. 
ACkNoWLEDgEMENt
National Centre for Epidemiology; Department of re-
spiratory viruses’ staff.
References
1.  Lamb RA,  Krug RM.: Orthomyxoviridae:  the  viruses  and  their 
replication.  In: Knipe DM, Howley PM, Griffin DE et al., editors. Fields 
Virology, 4th ed. Lippincott Williams & Wilkins. 2001: 1487–1531. 2. Mon-
tomoli  E  et  all.:  A method  for  detection  of  neuraminidase  antibody  in 
serum.  International Congress Series.  2004:  1263  . 3.  Lambré CR, 
Terzidis H, Greffard A, and Webster RG.: Measurement of anti-influenza 
neuraminidase antibody using a peroxidase-linked lectin and microtiter 
results of spectrofotometric detection results of PNA (ELISA)
Comparison of seroconversion
Fig. 6. Comparison B-specific NI titres of the sera pairs obtained with PNA test and takátsy-methods. 
Fig. 7. Seasonal vaccination induced HI responses and HI se-
roconversion.
155New Medicine 
4/2015
Detection of neuraminidase-inhibiting antibodies for measurement of influenza vaccine immunogenicity
plates coated with natural substrates. Journal of Immunological Methods. 
1990: 135: 49-57. 4. Gyula T.: A purified precipitated virus obtained by a 
new, simple method. Acta Microbiol. Hung. 1953 5.  WHO Global Influenza 
Surveillance Network: Manual for the laboratory diagnosis and virological 
surveillance of influenza. 2011. 6. HYPERLINK "http://www.ncbi.nlm.nih.
gov/pubmed/?term=Hirst%20GK%5Bauth%5D" Hirst GK.: Adsorption of 
influenza hemagglutinins and virus by red blood cells. HYPERLINK "http://
www.ncbi.nlm.nih.gov/pmc/journals/483/"J. Exp. Med. 1942:HYPERLINK 
"http://www.ncbi.nlm.nih.gov/pmc/issues/156529/" 76(2).   7. Salk, J.: A 
simplified procedure for titrating hemagglutinating capacity of  influenza 
virus and  the corresponding antibody. J.  Immunol. 1944. 87-98. 49(2). 
8. Gyula  T,  Barb K.:  Adaptation  of  the  influenza  neuraminidase  and 
neuraminidase-inhibition assays to the microtitrator system. Acta micro-
bial. Acad Sci. hung. 1979: 63-69. 26. 9. Warren, L.: The thiobarbituric 
assay of sialic acids. J. Biol. Chem. 1959. 1971-1975. 234. 10. Aymard-
Henry M, Coleman MT, Dowdle WR, Laver WG, Schild GC, Webster RG.: 
Influenzavirus neuraminidase and neuraminidase-inhibition  test  proce-
dures. Bull World Health Organ. 1973. 199–202. 48(2).
received: 09.11.2015
Accepted: 23.11.2015
Correspondence to:
*Mónika rózsa 
National Centre for Epidemiology
Department of respiratory Viruses
Albert Flórián (former gyáli) út 2-6, H-1097 Budapest, Hungary
tel.: +36 476-1100/2128
e-mail: rozsa.monika@oek.antsz.hu
